Drawing for VITEX-POWER

USPTO serial 75332371

VITEX-POWER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SNAPP, TINA LOUISE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VITEX-POWER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LESTER K ESSIG

LESTER K ESSIG RAY, QUINNEY & NEBEKERP O BOX 45385SALT LAKE CITY, UT 84145-0385UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005dietary supplements, vitamins and minerals, and herbs, extracts and amino acids for use as dietary supplements, all containing vitex or a vitex extract as an ingredient; and medications containing vitex or a vitex extract, namely, substances and preparations for use in the treatment of allergies, hay fever, nasal congestion, asthma, shortness of breath, tightness of the chest, wheezing, stress, tension, common cold, fatigue, diarrhea, gas pains, abdominal cramps, stomach distress, intestinal distress, bloating, distension, fullness, pressure, water-weight gain, swelling, inflammation, fevers, irregularity, constipation, sleep disorders, headaches, motion sickness, nausea, vomiting, low energy, dietary deficiencies, nutritional deficiencies, poor health, blood conditions, circulatory conditions, digestive conditions, premenstrual conditions, menstrual conditions, eye conditions, immune system conditions, metabolic conditions, conditions of the joints, and conditions associated with agingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 1999ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 24, 1999OP.TOPPOSITION TERMINATED NO. 999999—
Sep 24, 1999OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 18, 1999OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 15, 1999ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 29, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 1998NPUBNOTICE OF PUBLICATION—
Oct 19, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 1998CNEAEXAMINER'S AMENDMENT MAILED—
Oct 2, 1998CNEAEXAMINER'S AMENDMENT MAILED—
Sep 14, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance